This inventor holds 5 USPTO granted patents and 5 EPO patents. Top assignee: Fujifilm Manufacturing Europe B.v.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: Innovations of Hendrik Van Urk
Introduction
Hendrik Van Urk is a notable inventor based in Tilburg, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant gelatins. With a total of five patents to his name, Van Urk's work has implications in various medical and research applications.
Latest Patents
One of his latest patents is titled "Recombinant XRGD-enriched gelatins having high stability." This invention focuses on recombinant gelatin monomers and gelatins that consist of multimers of these monomers. The recombinant gelatins are particularly useful in applications involving cell attachment, such as cell culture work and medical applications involving anchor-dependent cells. Another significant patent is "Non-natural recombinant gelatins with enhanced functionality." This invention also concerns recombinant gelatin monomers and gelatins, which can be produced with enhanced stability, further expanding their potential applications.
Career Highlights
Hendrik Van Urk is currently employed at Fujifilm Manufacturing Europe B.V. His work at this company has allowed him to explore innovative solutions in the field of biotechnology. His patents reflect his commitment to advancing the functionality and stability of recombinant gelatins.
Collaborations
Throughout his career, Van Urk has collaborated with notable colleagues, including Arjo De Boer and Jan Bastiaan Bouwstra. These collaborations have likely contributed to the success and development of his innovative patents.
Conclusion
Hendrik Van Urk's contributions to the field of biotechnology through his patents on recombinant gelatins demonstrate his innovative spirit and dedication to advancing medical applications. His work continues to influence research and development in this important area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
